Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 4.877\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) Cc1ccc(O)c(C(CC(=O)NC(C)C)c2ccccc2)c1
(b) O=C(CCc1ccncc1)NC1CCCc2c1cnn2-c1ccc(F)cc1F
(c) O=[N+]([O-])C(=C1NCCN1)C(Sc1ccc2ccccc2c1)=C(Cl)Cl
(d) CCC(=O)Nc1ccc(/C(C)=N/NC(=O)c2c(-c3ccccc3Cl)noc2C)cc1
(e) Cc1ccc(S(=O)(=O)N2CCC(C(=O)N3CCN(Cc4ccccc4)CC3)CC2)cc1
Answer: e. Cc1ccc(S(=O)(=O)N2CCC(C(=O)N3CCN(Cc4ccccc4)CC3)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)N2CCC(C(=O)N3CCN(Cc4ccccc4)CC3)CC2)cc1
Cc1ccc(S(=O)(=O)N2CCC(C(=O)N3CCN(Cc4ccccc4)CC3)CC2)cc1
(4-benzylpiperazin-1-yl)-[1-(4-methylphenyl)sulfonylpiperidin-4-yl]methanone